OBJECTIVE: The aim of the current study is to evaluate quality of life in patients with different stages of dementia, MCI patients and healthy control subjects. METHODS: The study comprises a number of 92 elderly patients (23 healthy control subjects, 24 subjects diagnosed with mild cognitive impairment, 28 patients with early AD and 17 patients with moderate AD). Quality of life was measured with the SF36. RESULTS: We found significant differences between the diagnostic groups in the scales: perception of general health, vitality, limits in role performance due to emotional problems and mental health Generally, healthy control subjects and patients diagnosed with moderate AD showed better quality of life scores than patients with MCI and early stages of dementia. Additionally, we found a significant negative correlation between depression and all scales of the SF36. CONCLUSIONS: Our results confirm that mood seems to be the strongest predictor of quality of life in elderly persons and patients in different stages of cognitive decline.
OBJECTIVE: The aim of the current study is to evaluate quality of life in patients with different stages of dementia, MCI patients and healthy control subjects. METHODS: The study comprises a number of 92 elderly patients (23 healthy control subjects, 24 subjects diagnosed with mild cognitive impairment, 28 patients with early AD and 17 patients with moderate AD). Quality of life was measured with the SF36. RESULTS: We found significant differences between the diagnostic groups in the scales: perception of general health, vitality, limits in role performance due to emotional problems and mental health Generally, healthy control subjects and patients diagnosed with moderate AD showed better quality of life scores than patients with MCI and early stages of dementia. Additionally, we found a significant negative correlation between depression and all scales of the SF36. CONCLUSIONS: Our results confirm that mood seems to be the strongest predictor of quality of life in elderly persons and patients in different stages of cognitive decline.
Authors: Pierre Missotten; Gilles Squelard; Michel Ylieff; David Di Notte; Louis Paquay; Jan De Lepeleire; Ovide Fontaine Journal: Int J Geriatr Psychiatry Date: 2008-11 Impact factor: 3.485
Authors: Niels Janssen; Ron L Handels; Anders Wimo; Riitta Antikainen; Tiina Laatikainen; Hilkka Soininen; Timo Strandberg; Jaakko Tuomilehto; Miia Kivipelto; Silvia M A A Evers; Frans R J Verhey; Tiia Ngandu Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Leonie C P Banning; Eveline P C J Janssen; Renske E G Hamel; Marjolein de Vugt; Sebastian Köhler; Claire A G Wolfs; Saskia M Oosterveld; Rene J F Melis; Marcel G M Olde Rikkert; Roy P C Kessels; Yolande A L Pijnenburg; Ted Koene; Wiesje M van der Flier; Philip Scheltens; Pieter Jelle Visser; Frans R J Verhey; Pauline Aalten; Inez H G B Ramakers Journal: J Geriatr Psychiatry Neurol Date: 2019-10-23 Impact factor: 2.680